NEDD8 promotes neuronal ferritinophagy and ferroptosis in ischemic conditions by accelerating NRF2 degradation neddylation, thereby suppressing NRF2-mediated FTH1 transcription. Targeting the NEDD8/NRF2/FTH1 axis may represent a novel therapeutic strategy for mitigating ferroptosis-associated neuronal injury in ischemic stroke.
Rao et al. (Sun,) studied this question.